Clinical Trial Results:
A randomised, double-blind, parallel-group, placebo controlled study of
esomeprazole i.v. (bolus infusion of 80 mg followed by a continuous infusion
of 8 mg per hour) administered for 72 hours to assess prevention of
rebleeding in subjects that have undergone successful primary endoscopic
haemostasis of a bleeding peptic ulcer – the PUB study
Summary
|
|
EudraCT number |
2005-002441-39 |
Trial protocol |
GB FI SE NO DK ES AT DE |
Global completion date |
01 Dec 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
30 Jul 2016
|
First version publication date |
30 Jul 2016
|
Other versions |
|
Summary report(s) |
D961DC00001 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.